A Review of the Recent Advances in the Pharmacological Management of Parkinson's Disease.

Cureus · 2025 · PMC12551797 · PMID 41141087

Europe PMC DOI

hedged sentence

0.3470

closest p · 6.9× alpha

0.3470

boldest claim

The sentences

did not reach statistical significancep = 0.347not close (p > 0.1)

Although cabergoline was associated with a 43% lower risk of motor complications compared to LD, this difference did not reach statistical significance (HR = 0.57, p = 0.347).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.